Consultation display
Use of antipsychotic medication in care homes
- This consultation has completed. It ran from Friday, 3 March 2017 to Friday, 21 April 2017
- View the background to this consultation
- View all current consultations
Response to the consultation
Evidence submitted in response to this Consultation
- APS 01 College of Human and Health Sciences, Swansea University
PDF 658 KB View as HTML (1) 76 KB
- APS 02 Social Care Wales
PDF 186 KB View as HTML (2) 16 KB
- APS 03 Royal College of General Practitioners
PDF 116 KB View as HTML (3) 8 KB
- APS 04 Royal College of Occupational Therapists
PDF 242 KB View as HTML (4) 31 KB
- APS 05 Royal College of Nursing Wales
PDF 411 KB
- APS 06 Boots UK
PDF 261 KB
- APS 07 Royal College of Psychiatrists
PDF 487 KB
- APS 08 Alzheimer’s Society Cymru
PDF 534 KB
- APS 09 Royal Pharmaceutical Society
PDF 375 KB
- APS 10 Royal College of Speech and Language Therapists
PDF 197 KB View as HTML (10) 37 KB
- APS 11 National Pharmacy Association
PDF 398 KB
- APS 12 Welsh NHS Confederation
PDF 229 KB View as HTML (12) 37 KB
- APS 13 Care Forum Wales
PDF 385 KB View as HTML (13) 96 KB
- APS 14 Dementia Services Development Centre, Bangor University
PDF 344 KB View as HTML (14) 9 KB
- APS 15 All Wales Therapeutics and Toxicology Centre
PDF 218 KB View as HTML (15) 24 KB
- APS 16 The Care Homes Liaison Team, Cardiff and Vale University Health Board
PDF 465 KB
- APS 17 The British Psychological Society
PDF 1020 KB
- APS 18 Care and Social Services Inspectorate Wales
PDF 306 KB
- APS 19 Association of Directors of Social Services Cymru
PDF 746 KB
- APS AI 01 Additional information from the Royal College of Psychiatrists
PDF 2 MB
- APS AI 02 Additional information from Community Pharmacy Wales
PDF 303 KB
- APS AI 03 Additional information from Care and Social Services Inspectorate Wales
PDF 1 MB
- APS AI 04 Additional information from Hywel Dda University Health Board and Aneurin Bevan University Health Board
PDF 3 MB
- APS AI 05 Additional information from the Royal College of Speech and Language Therapists and the Royal College of Occupational Therapists
PDF 369 KB View as HTML (24) 25 KB
- APS AI 06 Additional information from the Royal Pharmaceutical Society
PDF 492 KB
Purpose of the consultation
The
Health, Social Care and Sport
Committee welcomed your views on the terms of reference for the inquiry.
Terms of reference
The
use of antipsychotic medication in care home settings, and the ways in which
its inappropriate use could be reduced, including the consideration of:
- the availability of data on the
prescribing of antipsychotics in care homes, to understand prevalence and
patterns of use;
- prescribing practices, including
implementation of clinical guidance and medication reviews;
- provision of alternative
(non-pharmacological) treatment options;
- training for health and care
staff to support the provision of person-centred care for care home
residents living with dementia;
- identifying best practice, and
the effectiveness of initiatives introduced so far to reduce inappropriate
prescribing of antipsychotics;
- use of antipsychotic medication
for people with dementia in other types of care settings.
Guidance
Submissions
should be no longer than five sides of A4, with numbered paragraphs, and should
focus on matters set out above. Please see guidance
for those providing evidence for committees.
The
deadline for responses was 21 April 2017.
Please send your views to: SeneddHealth@assembly.wales
Bilingual Policy
The
Committee welcomes contributions in English or Welsh, and we ask organisations
with Welsh Language policies/schemes to provide bilingual responses, where
applicable, in line with their public information policies.
Disclosure of Information
You
can find further details about how we will use your information at www.assembly.wales/InquiryPrivacy.
Please ensure that you have considered these details carefully before
submitting information to the Committee.